1. Home
  2. MXCT vs RGR Comparison

MXCT vs RGR Comparison

Compare MXCT & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • RGR
  • Stock Information
  • Founded
  • MXCT 1999
  • RGR 1949
  • Country
  • MXCT United States
  • RGR United States
  • Employees
  • MXCT N/A
  • RGR N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RGR Ordnance And Accessories
  • Sector
  • MXCT Health Care
  • RGR Industrials
  • Exchange
  • MXCT Nasdaq
  • RGR Nasdaq
  • Market Cap
  • MXCT 534.8M
  • RGR 627.3M
  • IPO Year
  • MXCT 2021
  • RGR N/A
  • Fundamental
  • Price
  • MXCT $3.85
  • RGR $39.62
  • Analyst Decision
  • MXCT Strong Buy
  • RGR
  • Analyst Count
  • MXCT 2
  • RGR 0
  • Target Price
  • MXCT $9.50
  • RGR N/A
  • AVG Volume (30 Days)
  • MXCT 448.2K
  • RGR 151.8K
  • Earning Date
  • MXCT 03-11-2025
  • RGR 02-19-2025
  • Dividend Yield
  • MXCT N/A
  • RGR 1.77%
  • EPS Growth
  • MXCT N/A
  • RGR N/A
  • EPS
  • MXCT N/A
  • RGR 1.77
  • Revenue
  • MXCT $45,599,000.00
  • RGR $535,643,000.00
  • Revenue This Year
  • MXCT N/A
  • RGR N/A
  • Revenue Next Year
  • MXCT $20.23
  • RGR $4.81
  • P/E Ratio
  • MXCT N/A
  • RGR $22.38
  • Revenue Growth
  • MXCT 19.85
  • RGR N/A
  • 52 Week Low
  • MXCT $3.17
  • RGR $34.11
  • 52 Week High
  • MXCT $5.26
  • RGR $48.20
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 35.05
  • RGR 73.01
  • Support Level
  • MXCT $4.06
  • RGR $34.82
  • Resistance Level
  • MXCT $4.32
  • RGR $40.83
  • Average True Range (ATR)
  • MXCT 0.20
  • RGR 0.87
  • MACD
  • MXCT -0.07
  • RGR 0.41
  • Stochastic Oscillator
  • MXCT 4.65
  • RGR 79.87

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: